ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,782Medicare Part D Prescriptions Filled, Including Refills
$904K Total Retail Price of All Prescriptions
618 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 1,055 933
LEVOTHYROXINE SODIUM 942 917
SIMVASTATIN 792 701
FUROSEMIDE 647 606
POTASSIUM CHLORIDE 611 568
HYDROCODONE-ACETAMINOPHEN 550 520 S3
PRAVASTATIN SODIUM 535 492
AMLODIPINE BESYLATE 527 510
ISOSORBIDE MONONITRATE ER 471 470
TRAMADOL HCL 469 460
LISINOPRIL 431 406
METOPROLOL TARTRATE 383 355
CEFUROXIME 331 309
AZITHROMYCIN 319 294
WARFARIN SODIUM 308 284
GABAPENTIN 304 272
TRIAMTERENE-HCTZ 290 272
LOSARTAN POTASSIUM 289 273
CLOPIDOGREL 287 277
METOPROLOL SUCCINATE 277 263
PANTOPRAZOLE SODIUM 267 262
CIPROFLOXACIN HCL 260 242
LOSARTAN-HYDROCHLOROTHIAZIDE 248 220
CARVEDILOL 238 217
SERTRALINE HCL 237 224
MELOXICAM 221 214
PLAVIX 220 217
GLIMEPIRIDE 216 188
ALLOPURINOL 215 214
ATENOLOL 210 175
DONEPEZIL HCL 203 195
TAMSULOSIN HCL 203 170
SPIRONOLACTONE 200 187
NEXIUM 192 180
DIOVAN HCT 188 177
TRAZODONE HCL 188 178
POLYETHYLENE GLYCOL 3350 187 169
PREDNISONE 175 174
DIGOXIN 172 156
BISOPROLOL-HYDROCHLOROTHIAZIDE 166 152
ZOLPIDEM TARTRATE 165 165
METFORMIN HCL 156 155
ATORVASTATIN CALCIUM 144 130
METFORMIN HCL ER 141 138
CLONIDINE HCL 137 125
NAMENDA 136 135
KLOR-CON 10 134 113
VESICARE 127 114
FAMOTIDINE 120 116
FLUOCINONIDE 117 114
NAPROXEN 106 81
CYCLOBENZAPRINE HCL 106 80 R
RISPERIDONE 105 93
NITROFURANTOIN MONO-MACRO 105 100
CITALOPRAM HBR 103 91
MECLIZINE HCL 96 95
AMLODIPINE BESYLATE-BENAZEPRIL 94 94
BENAZEPRIL HCL 92 89
RANITIDINE HCL 90 86
AMITRIPTYLINE HCL 90 87 R
PAROXETINE HCL 88 60
ISOSORBIDE DINITRATE 83 79
LEVEMIR 83 70
ADVAIR DISKUS 82 78
CYMBALTA 77 74
CARBIDOPA-LEVODOPA 74 74
ESCITALOPRAM OXALATE 73 73
EXELON 72 72
DILTIAZEM 24HR ER 71 70
SOTALOL 70 70
LEVOFLOXACIN 69 67
ALENDRONATE SODIUM 68 68
QUINAPRIL HCL 67 67
ACTOS 67 67
LANSOPRAZOLE 66 64
DIOVAN 65 58
MIRTAZAPINE 65 63
LIPITOR 65 59
VERAPAMIL ER 61 57
DILTIAZEM 24HR CD 61 53
GEMFIBROZIL 61 61
AGGRENOX 59 59
LEVETIRACETAM 57 45
PROAIR HFA 56 51
DOXYCYCLINE HYCLATE 54 50
DICLOFENAC SODIUM 54 44
AMPICILLIN TRIHYDRATE 53 52
FINASTERIDE 52 47
PRAMIPEXOLE DIHYDROCHLORIDE 52 52
CRESTOR 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.